Pollard, J., Shimada, H., Kapoor, S., Hoch, M., Dhamal, V., Agrawal, N., Rosko, C., Cardoso, A. P., Yanagimachi, M., Im, H. J., Metzler, M., Hijiya, N. (2025). Asciminib pediatric formulation shows a tolerable safety profile in pediatric patients with chronic myeloid leukemia in chronic phase (CML-CP): Second interim analysis from the ASC4KIDS study. Blood. https://doi.org/10.1182/blood-2025-7312